secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001493152-24-021078
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma raises $3.2M in registered direct offering; issues warrants at $4.35 per share
--------------------------------------------------------------------------------

- Gross proceeds of ~$3.2M from sale of 740,000 shares at $4.35/share in registered direct offering.
- Concurrent private placement of 740,000 warrants exercisable at $4.35, five-year term.
- Closing expected on or about May 23, 2024, subject to customary conditions.
- Roth Capital Partners acted as exclusive placement agent; fees and expenses will be deducted.
- Net proceeds to be used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/0001493152-24-021078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315224021078/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer